We have successfully advised the shareholders and management team on Ethos Partners’ investment in leading healthcare manufacturer and supplier Bray Group.
Ethos Partners, one of Europe’s most active lower mid-market investors, has acquired the entire issued share capital of Bray Group. The transaction, which is also being backed by investment manager Triple Point, will support the business in its ambitious plans to expand its product lines and client base in the UK and internationally.
Oxfordshire-based Bray Group operates through three established industry brands – Avoca, Portia, and Bray Healthcare – focused on skin and wound treatments and women’s health. The Group’s customers include national health services, hospitals, clinics, wholesalers, distributors, retail pharmacies and medical practitioners across 35 international markets, including the UK, Canada, Australia, France, Poland and the Middle East.
Our corporate team advising shareholders Randal Pakeman and Nicholas Jones and the new management team led by CEO Sally Naunton was led by partners Adam Percival and Victoria Elliott, supported by a nine strong legal team spanning our Birmingham, Nottingham and Manchester offices.